Which hedge funds own CPRXEUR? CATALYST PHARMACEUTICALS INC, Q2 2026 13F holders
43 tracked hedge funds disclosed a position in CPRXEUR (CATALYST PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $576.2m in total. The largest holder by portfolio weight is Versor Investments LP at 5.0% of its book. 25 opened a new position this quarter: Versor Investments LP, Glazer Capital, LLC, Chicago Capital Management, LLC, Kintayl Capital LP. 11 exited: Ishara Investments LP, Deerfield Management Company, L.P., Fundsmith (Terry Smith).
- 43
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 25
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 11
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $316m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $134m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $576m
- Combined value Sum of the holders' reported positions in the security.
- 3.5%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Ishara Investments LP | 2.1% | $2.0m |
| Deerfield Management Company, L.P. | 1.2% | $97.6m |
| Fundsmith (Terry Smith) | 0.2% | $20.9m |
| EntryPoint Capital, LLC | 0.1% | $484k |
| Campbell & CO Investment Adviser LLC | 0.05% | $934k |
| Jupiter Asset Management Ltd | 0.04% | $6.8m |
| Aquatic Capital Management LLC | 0.02% | $596k |
| Freestone Grove Partners LP | 0.01% | $1.7m |
| Walleye Capital LLC | 0.01% | $1.8m |
| Tudor Investment Corp ET AL | 0.0% | $505k |
| Capstone Investment Advisors, LLC | 0.0% | $284k |
Ownership over time
Who discovered CPRXEUR first? Beta
The run: Q2 2016 → Q4 2017, +451%
| JW Asset Management, LLC high conviction | Q4 2022 | – | +2.0 pts |
| Ikarian Capital, LLC | Q3 2023 | – | +1.7 pts |
| Quantedge Capital Pte Ltd | Q1 2022 | – | +1.4 pts |
| Armistice Capital, LLC | Q2 2019 | – | +1.4 pts |
| Deerfield Management Company, L.P. | Q4 2022 | – | +1.0 pts |
| Bridger Management, LLC | Q4 2023 | – | +0.3 pts |
| Mangrove Partners IM, LLC | Q1 2019 | – | −0.6 pts |
| Great Point Partners LLC | Q4 2017 | – | −1.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.